PHILADELPHIA--(BUSINESS WIRE)-- There has been increased focus on using crystals and the ever-changing, sometimes disappearing properties of polymorphs as significant scientific and business opportunities. IQPC’s Polymorphism & Crystallization Scientific Forum, taking place October 25- 27, 2010 in Philadelphia, PA will address these issues.
Attendees will hear the latest pharmaceutical research and scientific advances for polymorphism and crystallization. Topics to be discussed at the event include:
The audience for this event comprises of professionals specializing in chemistry, sciences, chemical engineering, physical properties, pre-formulation, drug delivery, pharmaceutics, solid state and toxicology.
Plus, attendees have the opportunity to attend three pre-conference workshops on the following topics:
The speaker faculty for this event includes: Pfizer, Novartis, Abbott Laboratories, Astrazeneca, GlaxoSmithKline, University of Michigan, Vertex Pharmaceuticals and more.
IQPC produces more than 1,500 events annually around the world, and continues to grow. Founded in 1973, IQPC now has offices in major cities across five continents. IQPC leverages a global research base of best practices to produce a cross industry of information-sharing forums.
Karen Richardson, 646-378-6034
KEYWORDS: United States North America Pennsylvania
INDUSTRY KEYWORDS: Health Biotechnology Pharmaceutical Research Other Science Science